Onafowokan Oluwatobi O, Ahmad Waleed, McFarland Kimberly, Williamson Tyler K, Tretiakov Peter, Mir Jamshaid M, Das Ankita, Bell Joshua, Naessig Sara, Vira Shaleen, Lafage Virginie, Paulino Carl, Diebo Bassel, Schoenfeld Andrew, Hassanzadeh Hamid, Jankowski Pawel P, Hockley Aaron, Passias Peter Gust
Department of Orthopedic and Neurologic Surgery, New York Spine Institute, NYU Langone Orthopedic Hospital, New York.
Department of Orthopedics, University of Virginia School of Medicine, Charlottesville, VA.
J Craniovertebr Junction Spine. 2024 Jan-Mar;15(1):45-52. doi: 10.4103/jcvjs.jcvjs_186_23. Epub 2024 Mar 13.
With the increasing amount of elective spine fusion patients presenting with cardiac disease and congestive heart failure, it is becoming difficult to assess when it is safe to proceed with surgery. Assessing the severity of heart failure (HF) through ejection fraction may provide insight into patients' short- and long-term risks.
The purpose of this study was to assess the severity of HF on perioperative outcomes of spine fusion surgery patients.
STUDY DESIGN/SETTING: This was a retrospective cohort study of the PearlDiver database.
We enrolled 670,526 patients undergoing spine fusion surgery.
Thirty-day and 90-day complication rates, discharge destination, length of stay (LOS), physician reimbursement, and hospital costs.
Patients undergoing elective spine fusion surgery were isolated and stratified by preoperative HF with preserved ejection fraction (P-EF) or reduced ejection fraction (R-EF) (International Classification of Diseases-9: 428.32 [chronic diastolic HF] and 428.22 [chronic systolic HF]). Means comparison tests (Chi-squared and independent samples t-tests, as appropriate) compared differences in demographics, diagnoses, comorbidities, procedural characteristics, LOS, 30-day and 90-day complication outcomes, and total hospital charges between those diagnosed with P-EF and those not R-EF. Binary logistic regression assessed the odds of complication associated with HF, controlling for levels fused (odds ratio [OR] [95% confidence interval]). Statistical significance was set at < 0.05.
Totally 670,526 elective spine fusion patients were included. Four thousand and seventy-seven were diagnosed with P-EF and 2758 R-EF. Overall, P-EF patients presented with higher rates of morbid obesity, chronic kidney disease, chronic obstructive pulmonary disease, diabetes mellitus, and hypertension (all < 0.001). In relation to No-HF, P-EF patients had higher rates of 30-day major complications including pulmonary embolism, pneumonia, cerebrovascular accident (CVA), myocardial infarctions (MI), sepsis, and death (all < 0.001). Furthermore, P-EF was associated significantly with increased odds of pneumonia (OR: 2.07 [1.64-2.56], < 0.001) and sepsis (OR: 2.09 [1.62-2.66], < 0.001). Relative to No-HF, R-EF was associated with significantly higher odds of MI (OR: 3.66 [2.34-5.47]), CVA (OR: 2.70 [1.67-4.15]), and pneumonia (OR: 1.85 [1.40-2.40]) (all < 0.001) postoperative within 30 days. Adjusting for prior history of MI, CAD, and the presence of a pacemaker R-EF was a significant predictor of an MI 30 days postoperatively (OR: 2.2 [1.14-4.32], = 0.021). Further adjusting for history of CABG or stent placement, R-EF was associated with higher odds of CVA (OR: 2.11 [1.09-4.19], = 0.028) and MI (OR: 2.27 [1.20-4.43], = 0.013).
When evaluating the severity of HF before spine surgery, R-EF was associated with a higher risk of major complications, especially the occurrence of a myocardial infarction 30 days postoperatively. During preoperative risk assessment, congestive HF should be considered thoroughly when thinking of postoperative outcomes with emphasis on R-EF.
随着接受择期脊柱融合手术且患有心脏病和充血性心力衰竭的患者数量不断增加,评估何时进行手术安全变得愈发困难。通过射血分数评估心力衰竭(HF)的严重程度可能有助于了解患者的短期和长期风险。
本研究旨在评估心力衰竭严重程度对脊柱融合手术患者围手术期结局的影响。
研究设计/地点:这是一项对PearlDiver数据库进行的回顾性队列研究。
我们纳入了670526例接受脊柱融合手术的患者。
30天和90天并发症发生率、出院去向、住院时间(LOS)、医生报销费用和医院成本。
将接受择期脊柱融合手术的患者分离出来,并根据术前射血分数保留(P-EF)或降低(R-EF)的心力衰竭情况进行分层(国际疾病分类-9:428.32[慢性舒张性心力衰竭]和428.22[慢性收缩性心力衰竭])。均值比较检验(适当情况下采用卡方检验和独立样本t检验)比较了P-EF组和非R-EF组在人口统计学、诊断、合并症、手术特征、住院时间、30天和90天并发症结局以及总住院费用方面的差异。二元逻辑回归评估了与心力衰竭相关的并发症发生几率,并对融合节段水平进行了控制(比值比[OR][95%置信区间])。统计学显著性设定为<0.05。
共纳入670526例择期脊柱融合手术患者。其中4077例被诊断为P-EF,2758例为R-EF。总体而言,P-EF患者的病态肥胖、慢性肾脏病、慢性阻塞性肺疾病、糖尿病和高血压发生率更高(均<0.001)。与无心力衰竭患者相比,P-EF患者30天主要并发症发生率更高,包括肺栓塞、肺炎、脑血管意外(CVA)、心肌梗死(MI)、败血症和死亡(均<0.001)。此外,P-EF与肺炎(OR:2.07[1.64 - 2.56],<0.001)和败血症(OR:2.09[1.62 - 2.66],<0.001)发生几率的显著增加相关。相对于无心力衰竭患者,R-EF与术后30天内MI(OR:3.66[2.34 - 5.47])、CVA(OR:2.70[1.67 - 4.15])和肺炎(OR:1.85[1.40 - 2.40])的发生几率显著更高相关(均<0.001)。调整MI、CAD既往史和起搏器的存在情况后,R-EF是术后30天发生MI的显著预测因素(OR:2.2[1.14 - 4.32],=0.021)。进一步调整冠状动脉搭桥术或支架置入史后,R-EF与CVA(OR:2.11[1.09 - 4.19],=0.028)和MI(OR:2.27[1.20 - 4.43],=0.013)的发生几率更高相关。
在评估脊柱手术前心力衰竭的严重程度时,R-EF与主要并发症的较高风险相关,尤其是术后30天发生心肌梗死的风险。在术前风险评估期间,考虑术后结局时应充分考虑充血性心力衰竭,重点关注R-EF。